Bikhazi G B, Leung I, Flores C, Mikati H M, Foldes F F
Department of Anesthesiology, University of Miami School of Medicine, FL 33101.
Anesth Analg. 1988 Jan;67(1):1-8.
The effect of calcium channel blockers (Ca-antagonists) on the potency and reversibility of muscle relaxants (MR) was investigated in the in vitro phrenic nerve-hemidiaphragm and in vivo sciatic nerve-tibialis anterior preparation of rats. To increase the relevance of the experimental findings to the clinical situation, the [Ca++] and [Mg++] in vitro were the same as in the plasma of rats and humans and the stimulation parameters used in vitro and in vivo were similar to those that elicit voluntary movements of the muscles used. Both verapamil and nifedipine significantly decreased the I50 and I90 of d-tubocurarine (d-Tc), pancuronium, vecuronium, and atracurium in vitro and those of the first three MR in vivo (P less than 0.001). In vitro, the depression of the force of contraction of the diaphragm (P) caused by all the Ca-antagonist-MR combinations could be reversed only partially by washout, neostigmine, or 4-aminopyridine. In vivo, because of limitations imposed by their cardiovascular depressant effect, the muscles were exposed to lower concentrations of Ca-antagonists for shorter periods. Under these circumstances the decrease of P caused by all Ca-antagonist-MR combinations recovered spontaneously close to control levels. This study indicates that acute administration of verapamil during anesthesia may increase MR potency, but it is unlikely that spontaneous recovery or reversibility of the residual neuromuscular (NM) block at the end of anesthesia will be significantly affected. However, long-term administration of Ca-antagonists may make difficult the reversal of the residual NM block.
在大鼠的体外膈神经 - 半膈肌以及体内坐骨神经 - 胫前肌标本中,研究了钙通道阻滞剂(钙拮抗剂)对肌肉松弛剂(MR)效能及可逆性的影响。为了使实验结果与临床情况更相关,体外实验中的[Ca++]和[Mg++]与大鼠和人类血浆中的相同,且体外和体内使用的刺激参数与引发所用肌肉自主运动的参数相似。维拉帕米和硝苯地平在体外均显著降低了d - 筒箭毒碱(d - Tc)、泮库溴铵、维库溴铵和阿曲库铵的I50和I90,在体内也降低了前三种肌肉松弛剂的I50和I90(P < 0.001)。在体外,所有钙拮抗剂 - 肌肉松弛剂组合引起的膈肌收缩力(P)降低,仅通过冲洗、新斯的明或4 - 氨基吡啶只能部分逆转。在体内,由于其心血管抑制作用带来的限制,肌肉暴露于较低浓度钙拮抗剂的时间较短。在这些情况下,所有钙拮抗剂 - 肌肉松弛剂组合引起的P降低会自发恢复至接近对照水平。本研究表明,麻醉期间急性给予维拉帕米可能会增加肌肉松弛剂的效能,但麻醉结束时残余神经肌肉(NM)阻滞的自发恢复或可逆性不太可能受到显著影响。然而,长期给予钙拮抗剂可能会使残余NM阻滞的逆转变得困难。